Good price  online

products details

Created with Pixso. Home Created with Pixso. Products Created with Pixso.
Chest Lung Cancer Drugs
Created with Pixso. Dacomitinib Tablets 15mg 30 Tablets Box Second Generation Irreversible Pan HER EGFR TKI for EGFR Mutant Advanced NSCLC

Dacomitinib Tablets 15mg 30 Tablets Box Second Generation Irreversible Pan HER EGFR TKI for EGFR Mutant Advanced NSCLC

Brand Name: Sichuan Kelun Pharmaceutical Co., Ltd.
Model Number: Dacomitinib KL-20254254
MOQ: Negotiable
Price: Please contact a specialist WhatsApp:55342706
Delivery Time: Negotiable
Payment Terms: Western Union,MoneyGram,T/T
Detail Information
Place of Origin:
Chengdu, Sichuan, China
Certification:
NMPA/GMP
Packaging Details:
Negotiable
Supply Ability:
Negotiable
Highlight:

Irreversible Pan HER EGFR TKI

,

Second Gen EGFR Mutant NSCLC

,

Covalent EGFR HER2 HER4 Inhibitor

Product Description

Dacomitinib 15mg x 30 Tablets

[Product Name]

Generic Name: Dacomitinib

Specification: 15mg x 30 Tablets

[Active Ingredient]

Dacomitinib

[Indications]

First-line EGFR exon 19 del or L858R NSCLC. 15mg: second dose-reduction level from 45mg starting dose.

[Mechanism of Action]

Second-gen irreversible covalent ErbB family (EGFR/HER2/HER4) inhibitor. ARCHER 1050: superior OS vs gefitinib in first-line EGFR-mutant NSCLC.

[Dosage]

Starting dose: 45mg daily. Reduce to 30mg then 15mg for toxicity. Prophylactic loperamide and skin care recommended.

[Adverse Reactions]

Diarrhea (87%), rash (78%), paronychia (62%), stomatitis (44%). ILD (fatal), severe diarrhea, hepatotoxicity.

[Storage]

Store below 30C. Keep out of reach of children.

[Shelf Life]

24 months

Approval: H20254254